Overall rank by patents
#2,766
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Bardy Diagnostics, Inc.
USPTO PatentsView assignee record - 139 granted patents across 15 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
139
Total patents granted
15
CPC technology areas
18.1
Avg claims per patent
+28%
5-year filing velocity
The verdict
Bardy holds 139 US patents across 15 technology areas, rank #2,766 of 50,000 tracked assignees.
- #2,766
- of 50,000 US assignees by volume
- Top 18%
- by Innovation Score (47.5/100)
- 18.1
- avg claims per patent
- +28%
- filing velocity, last 5 yrs
Portfolio overview
Bardy Diagnostics, Inc. has been granted 139 US utility patents between 2015 and 2025, placing Bardy Diagnostics, Inc. at rank #2,766 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Bardy Diagnostics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Bardy sits between Reald Spark, Llc (140 patents, rank #2,762) and Creative Technology Corporation (139 patents, rank #2,770) - the closest US assignees by grant volume. The composite Innovation Score of 47.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 78 grants, compared with 61 in the 2015–2019 window, a +28% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Bardy Diagnostics, Inc.'s 18.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bardy Diagnostics, Inc. against peers pursuing similar technology classes.
Who files at Bardy's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Reald Spark
RealD Spark, LLC
140 patents
- The United States…
The United States of America, as represented by Secretary of the Navy
140 patents
- Xencor
Xencor, Inc.
140 patents
- Bar-ilan Universi…
Bar-Ilan University
139 patents
- Beijing Institute…
Beijing Institute of Technology
139 patents
- Cytiva Sweden AB
CYTIVA SWEDEN AB
139 patents
- Continuous Compos…
Continuous Composites Inc.
139 patents
- Creative Technolo…
Creative Technology Corporation
139 patents
- Bardy Diagnostics ◀
Bardy Diagnostics, Inc.
139 patents
What this shows Bardy holds 139 patents at rank #2,766, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Bardy
By rank, the assignees closest to #2,766 in granted patent volume.
- Reald Spark, Llc #2,762 · 140 patents
- The United States Of America, As Represented By Secretary Of The Navy #2,763 · 140 patents
- Xencor, Inc. #2,764 · 140 patents
- Bar-ilan University #2,765 · 139 patents
- Beijing Institute Of Technology #2,767 · 139 patents
- Cytiva Sweden AB #2,768 · 139 patents
- Continuous Composites Inc. #2,769 · 139 patents
- Creative Technology Corporation #2,770 · 139 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Bardy's primary technology class.
- Covidien Lp 5,709 in class
- Koniniklijke Philips N.v. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag Gmbh International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- Depuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Bardy's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 0.7% |
| 2016 | 8 | 5.8% |
| 2017 | 20 | 14.4% |
| 2018 | 12 | 8.6% |
| 2019 | 20 | 14.4% |
| 2020 | 19 | 13.7% |
| 2021 | 10 | 7.2% |
| 2022 | 15 | 10.8% |
| 2023 | 22 | 15.8% |
| 2024 | 6 | 4.3% |
| 2025 | 6 | 4.3% |
Which technologies does Bardy Diagnostics, Inc. patent most?
Top 15 of 15 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does Bardy Diagnostics, Inc. hold?
Bardy Diagnostics, Inc. holds 139 US granted patents filed between 2015 and 2025, spanning 15 technology areas.
What is Bardy Diagnostics, Inc.'s Innovation Score?
Bardy Diagnostics, Inc. has an Innovation Score of 47.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Bardy Diagnostics, Inc. focus on?
Bardy Diagnostics, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 130 patents. The company has filed patents in 15 CPC subclasses total.
Is Bardy Diagnostics, Inc.'s patent filing rate increasing or decreasing?
Bardy Diagnostics, Inc.'s recent filing velocity is +28% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Bardy Diagnostics, Inc.'s patents?
Bardy Diagnostics, Inc.'s patents average 18.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Bardy Diagnostics, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Bardy's 139 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Bardy ranks #2,766 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.